Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

165.35
+0.69500.42%
Volume:182.07K
Turnover:29.76M
Market Cap:9.89B
PE:-24.45
High:165.73
Open:164.29
Low:161.01
Close:164.65
Loading ...

Ascendis Pharma AS (ASND) Q4 2024 Earnings Call Highlights: Strategic Growth and Market ...

GuruFocus.com
·
14 Feb

Ascendis Pharma A/S Earnings Call Highlights Growth and Challenges

TIPRANKS
·
14 Feb

Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?

Benzinga
·
14 Feb

European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

MT Newswires Live
·
14 Feb

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
14 Feb

Stock Track | Ascendis Pharma Soars Over 11% on Upbeat Q4 Results, Share Buyback Plan

Stock Track
·
13 Feb

Stock Track | Ascendis Pharma Soars Over 8% Pre-Market on Strong Q4 Earnings, Buyback Plan

Stock Track
·
13 Feb

Ascendis Pharma (ASND) Receives a Buy from J.P. Morgan

TIPRANKS
·
13 Feb

Ascendis Pharma price target lowered to $192 from $203 at BofA

TIPRANKS
·
13 Feb

Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs

MT Newswires Live
·
13 Feb

Ascendis Pharma a/S : Jefferies Raises Target Price to $223 From $194

THOMSON REUTERS
·
13 Feb

Ascendis Pharma A/S Reports Strong 2024 Financial Growth

TIPRANKS
·
13 Feb

Ascendis Pharma A/S reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement Of Certain Rsus

Reuters
·
13 Feb

Stock Track | Ascendis Pharma Soars 6% After Hours on Q4 Beat, Buyback Plan

Stock Track
·
13 Feb

Ascendis Pharma announces share repurchase program, settlement of certain RSUs

TIPRANKS
·
13 Feb